Trial Profile
Retrospective Chart Review of Perampanel (Fycompa) Use in the Treatment of Pediatric Epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2017
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 05 May 2017 New trial record
- 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology